3-methyladenosine has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, Y; Liu, D; Patel, R; Qin, ZH; Ren, X; Shih, IM; Wu, H; Yang, JM; Yap, KL; Zhang, L; Zhang, Y | 1 |
1 other study(ies) available for 3-methyladenosine and Ovarian Neoplasms
Article | Year |
---|---|
NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
Topics: Adaptor Proteins, Signal Transducing; Adenosine; Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; HMGB1 Protein; Humans; Microtubule-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Transport; Repressor Proteins; RNA Interference; Sequestosome-1 Protein | 2012 |